SouthViews No. 182, 11 July 2019
The most expensive drug in the history of the pharmaceutical industry
By Germán Velásquez
On May 27, 2019 the US FDA gave marketing authorization for Zolgensma gene therapy, from the Swiss firm Novartis. The price of the drug, administered in a single dose, is 2.125 million dollars, making it the most expensive drug in the history of the pharmaceutical industry.
Download the SouthViews:
This article was tagged: Access to Health, Access to Medicines, Big Pharma, Novartis, Pharmaceuticals, spinal muscular atrophy (SMA), Zolgensma gene therapy